TYPHIBEV, a second TCV, was prequalified by WHO in 2020. Nepal and Malawi introduced TYPHIBEV into their routine immunization programs in 2022 and 2023, respectively.
Read moreTYPHIBEV, a second TCV, was prequalified by WHO in 2020. Nepal and Malawi introduced TYPHIBEV into their routine immunization programs in 2022 and 2023, respectively.
Read moreTCV has also been used safely and effectively as part of outbreak response efforts in Pakistan, Zimbabwe, and Fiji. In Pakistan, TCV was used to help control an ongoing XDR ...
Read more